Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03425006 |
|---|---|
| Brief Title: | Pembrolizumab and Itacitinib (INCB039110) for Non-Small Cell Lung Cancer |
| First Submitted : | January 22, 2018 |
| First Submitted that Met QC Criteria : | February 5, 2018 |
| First Posted : | February 7, 2018 |
| Certification/Extension First Submitted : | May 24, 2022 |
| Certification/Extension First Submitted that Met QC Criteria : | May 25, 2022 |
| Certification/Extension First Posted : | May 27, 2022 |
| Last Update Submitted that Met QC Criteria : | May 25, 2022 |
| Last Update Posted : | May 27, 2022 |